Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging

James Monkman1, Afshin Moradi1, Joseph Yunis1,2

  • 1Faculty of Medicine, Frazer Institute, The University of Queensland, 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.

Insights

Spatial analysis of immune cells in non-small cell lung cancer (NSCLC) reveals key interactions. Regulatory T cells (Tregs) in non-responders and specific immune cell neighborhoods in responders correlate with immunotherapy outcomes.

Area of Science:

  • Immunology
  • Computational Biology
  • Oncology

Background:

  • Immune cell spatial localization within tumors is crucial for understanding intercellular communication and clinical outcomes.
  • Non-small cell lung cancer (NSCLC) patient responses to PD-1 axis immunotherapy are influenced by the tumor microenvironment.
  • Highly multiplexed imaging techniques enable detailed profiling of cellular interactions.

Purpose of the Study:

  • To develop and apply an analysis pipeline for highly multiplexed CODEX data in NSCLC patients.
  • To phenotype and profile spatial features and immune cell interactions in relation to PD-1 axis immunotherapy response.
  • To identify spatial patterns associated with clinical outcomes and overall survival.

Main Methods:

  • Utilized a CODEX data analysis pipeline for spatial feature and interaction profiling.
  • Performed proximity-based interaction analysis between immune cell types and tumor cells.
  • Conducted cellular neighborhoods analysis to assess immune cell clustering and associations with response.
  • Inferred regulatory functions between immune cells and tumor cells.

Main Results:

  • Regulatory T cells (Tregs) were enriched in non-responding NSCLC patients, localized in stromal and peripheral tumor margins.
  • Proximity interactions between Tregs and monocytes/CD8+ T cells were more frequent in non-responders.
  • Macrophages were found near HLADR+ tumor cells in responders; specific immune cell neighborhoods (macrophages, CD4+ T cells, CD8+ T cells) were associated with favorable response.
  • Macrophages exhibited an immunosuppressive phenotype against CD4+ and CD8+ T cells, particularly in immunotherapy-refractory patients.

Conclusions:

  • Spatial immune cell distribution and interactions significantly impact NSCLC patient response to PD-1 axis immunotherapy.
  • Specific immune cell neighborhoods and interactions, such as Treg enrichment or macrophage immunosuppression, can predict clinical outcomes.
  • These findings highlight potential biomarkers for immunotherapy response and offer insights into tumor microenvironment function.

Related Concept Videos